Analyst Rating Update on St. Jude Medical (STJ)

St. Jude Medical (STJ) : The consensus on St. Jude Medical (STJ) based on 19 analyst recommendation on the company stock is 2.89, which is interpreted as a Hold recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 1 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 18 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

St. Jude Medical (STJ) : The consensus price target for St. Jude Medical (STJ) is $76.09 for the short term with a standard deviation of $12.01. The most optimist securities analyst among the 16 who monitor the stock believes that the stock can reach $89, however, the pessimist price target for the company is $54.

Company shares have received an average consensus rating of Hold for the current week


St. Jude Medical (NYSE:STJ): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $83.50 and $83.30 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $83.56. The buying momentum continued till the end and the stock did not give up its gains. It closed at $83.53, notching a gain of 0.01% for the day. The total traded volume was 1,102,077 . The stock had closed at $83.52 on the previous day.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.